The fields of oncology and biotechnology are entering a period of rapid growth and transformation. It is an exciting time for physicians, researchers, and allied healthcare professionals. We are honored to be apart of the process.
We are privileged to bring you such stories as the shrinking oncology workforce and the exciting news about Tykerb (GSK's advanced breast cancer drug) as we continue evolving our publication both in style and content.
With this and every issue of Oncology & Biotech News, we seek to provide clinicians with practical news with a global perspective. As we move forward, it is our goal to provide more information from markets outside the United States. Your input is essential to developing this publication into a useful tool for you in your daily practice.